Inventor
CHWALISZ KRISTOF
US24 patents
⚠️ This page may combine multiple inventors who share the name “CHWALISZ KRISTOF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
14 patentsUS5789442AAug 4, 1998
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
SCHERING AG135 citations99
US5719136AFeb 17, 1998
Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women
SCHERING AG114 citations96
US6316432B1Nov 13, 2001
Antigestagenically active steroids with a flourinated 17 α-alkyl chain
SCHERING AG40 citations95
US7148213B2Dec 12, 2006
Antigestagenically active steroids with a fluorinated 17α-alkyl chain
SCHERING AG18 citations92
US6806263B2Oct 19, 2004
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain
SCHERING AG17 citations92
US6503895B2Jan 7, 2003
Antigestagenically active steroids with a fluorinated 17α-alkyl chain
SCHERING AG22 citations92
US6225297B1May 1, 2001
Combination contraceptive
SCHERING AG57 citations92
US6028106AFeb 22, 2000
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
SCHERING AG23 citations92
US5906987AMay 25, 1999
Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
SCHERING AG40 citations92
US6043234AMar 28, 2000
Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen
SCHERING AG25 citations91
US6143754ANov 7, 2000
Competitive progesterone antagonist for demand-oriented female birth control
SCHERING AG14 citations70
US6333350B1Dec 25, 2001
Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility
SCHERING AG3 citations63
US6362237B1Mar 26, 2002
Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
SCHERING AG5 citations61
US6096732AAug 1, 2000
Steroid esters, process for their production and their pharmaceutical use
SCHERING AG0 citations52
ABBVIE INC
4 patentsUS11045470B2Jun 29, 2021
Methods of treating heavy menstrual bleeding
ABBVIE INC4 citations81
US10881659B2Jan 5, 2021
Methods of treating heavy menstrual bleeding
ABBVIE INC4 citations81
US11707464B2Jul 25, 2023
Methods of treating heavy menstrual bleeding
ABBVIE INC1 citations70
US11344551B2May 31, 2022
Methods of treating heavy menstrual bleeding
ABBVIE INC2 citations70
UNIV TEXAS
2 patentsUS5811416ASep 22, 1998
Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
UNIV TEXAS122 citations98
US6613757B1Sep 2, 2003
Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
UNIV TEXAS19 citations92